IL96793A0 - Polyamines useful as antagonists of excitatory amino acid neurotransmitters - Google Patents

Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Info

Publication number
IL96793A0
IL96793A0 IL96793A IL9679390A IL96793A0 IL 96793 A0 IL96793 A0 IL 96793A0 IL 96793 A IL96793 A IL 96793A IL 9679390 A IL9679390 A IL 9679390A IL 96793 A0 IL96793 A0 IL 96793A0
Authority
IL
Israel
Prior art keywords
amino acid
excitatory amino
neurotransmitters
antagonists
polyamines useful
Prior art date
Application number
IL96793A
Other languages
English (en)
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Publication of IL96793A0 publication Critical patent/IL96793A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL96793A 1990-01-02 1990-12-26 Polyamines useful as antagonists of excitatory amino acid neurotransmitters IL96793A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46020790A 1990-01-02 1990-01-02
US07/560,699 US5037846A (en) 1990-01-02 1990-07-31 Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Publications (1)

Publication Number Publication Date
IL96793A0 true IL96793A0 (en) 1991-09-16

Family

ID=27039601

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96793A IL96793A0 (en) 1990-01-02 1990-12-26 Polyamines useful as antagonists of excitatory amino acid neurotransmitters

Country Status (23)

Country Link
US (1) US5037846A (fr)
EP (1) EP0436332B1 (fr)
JP (1) JPH0714913B2 (fr)
KR (1) KR930007250B1 (fr)
CN (1) CN1053059A (fr)
AT (1) ATE133941T1 (fr)
AU (2) AU619700B2 (fr)
CA (1) CA2033480C (fr)
DE (1) DE69025305T2 (fr)
DK (1) DK0436332T3 (fr)
ES (1) ES2083439T3 (fr)
FI (1) FI93644C (fr)
GR (1) GR3019487T3 (fr)
HU (1) HUT56063A (fr)
IE (1) IE70757B1 (fr)
IL (1) IL96793A0 (fr)
MY (1) MY104588A (fr)
NO (1) NO173733C (fr)
NZ (1) NZ236550A (fr)
PH (1) PH27608A (fr)
PL (1) PL165647B1 (fr)
PT (1) PT96389A (fr)
YU (1) YU247590A (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227397A (en) * 1989-04-28 1993-07-13 Pfizer Inc. Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5677288A (en) * 1991-05-15 1997-10-14 Cypros Pharmaceutical Corporation Use of aminoglycosides to protect against excitotoxic neuron damage
BR9206403A (pt) * 1991-08-23 1994-12-27 Pfizer Aril-poliaminas sintéticas como antagonistas de neurotransmissores aminoácidos excitadores
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US6750244B2 (en) 1993-02-08 2004-06-15 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6017965A (en) * 1993-02-08 2000-01-25 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6071970A (en) * 1993-02-08 2000-06-06 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US7087765B2 (en) 1995-06-07 2006-08-08 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
US6211245B1 (en) 1993-02-08 2001-04-03 Nps Pharmaceuticals, Inc. Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
DE69434889D1 (de) 1994-02-08 2007-01-11 Nps Pharma Inc An einer neuen Stelle von Rezeptorabhängigen Kalziumkanälen wirkende Verbindungen zur Behandlung von neurologischen Erkrankungen
US5688764A (en) * 1995-02-17 1997-11-18 Nps Pharmaceuticals, Inc. Insecticidal peptides from spider venom
US5874298A (en) * 1995-02-17 1999-02-23 Nps Pharmaceuticals, Inc. Insecticidal toxins from Bracon hebetor nucleic acid encoding said toxin and methods of use
US5674846A (en) * 1996-09-04 1997-10-07 Nps Pharmaceuticals, Inc. Insecticidal peptides from Segestria sp. spider venom
WO1998036743A1 (fr) * 1997-02-21 1998-08-27 Cypros Pharmaceutical Corporation Composes poly-guanidino neuroprotecteurs bloquant les canaux a calcium n et p/q presynaptiques
US7087648B1 (en) 1997-10-27 2006-08-08 The Regents Of The University Of California Methods for modulating macrophage proliferation using polyamine analogs
AU2003231670B2 (en) * 1997-10-27 2006-06-08 Slil Biomedical Corporation Methods for modulating macrophage proliferation using polyamine analogs
US8198334B2 (en) * 1997-10-27 2012-06-12 Pathologica Llc Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
WO2002053519A2 (fr) * 2001-01-08 2002-07-11 Mediquest Therapeutics, Inc. Analogues de polyamine hydrophobe et procedes d'utilisation correspondants
JP2005510524A (ja) 2001-11-16 2005-04-21 アルス・セラピー・デベロツプメント・フアンデーシヨン・インコーポレーテツド ポリアミン経路の調節による神経変性障害の治療
EP1448183A2 (fr) * 2001-11-16 2004-08-25 ALS Therapy Development Foundation, Inc. Traitement de troubles neurodegeneratifs par modulation de la voie polyamine
BRPI0517551A (pt) * 2004-10-04 2008-10-14 Cellgate Inc análogos de poliamina como agentes terapêuticos para doenças oculares
CN101300004B (zh) * 2005-09-23 2013-08-21 帕瑟洛吉卡有限公司 使用多胺类似物治疗病毒感染的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925664A (en) * 1986-10-20 1990-05-15 University Of Utah Spider toxins and methods for their use as blockers of calcium channels and amino acid receptor function
IT1206078B (it) * 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
DD298412A5 (de) * 1989-04-28 1992-02-20 ������@���Kk�� Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters

Also Published As

Publication number Publication date
NO173733C (no) 1994-01-26
ES2083439T3 (es) 1996-04-16
NO905616L (no) 1991-07-03
KR910014123A (ko) 1991-08-31
US5037846A (en) 1991-08-06
FI906466L (fi) 1991-07-03
NZ236550A (en) 1992-05-26
PL165647B1 (pl) 1995-01-31
AU1592692A (en) 1992-07-09
IE70757B1 (en) 1996-12-30
YU247590A (sh) 1993-10-20
CA2033480A1 (fr) 1991-07-03
PH27608A (en) 1993-08-18
FI906466A0 (fi) 1990-12-31
NO905616D0 (no) 1990-12-28
FI93644B (fi) 1995-01-31
EP0436332A2 (fr) 1991-07-10
MY104588A (en) 1994-04-30
IE904734A1 (en) 1991-07-17
JPH04210677A (ja) 1992-07-31
GR3019487T3 (en) 1996-07-31
DE69025305T2 (de) 1996-06-27
AU619700B2 (en) 1992-01-30
AU640565B2 (en) 1993-08-26
CA2033480C (fr) 1995-11-21
PT96389A (pt) 1991-10-15
DK0436332T3 (da) 1996-03-11
FI93644C (fi) 1995-05-10
HUT56063A (en) 1991-07-29
KR930007250B1 (ko) 1993-08-04
PL288490A1 (en) 1991-12-16
DE69025305D1 (de) 1996-03-21
EP0436332A3 (en) 1991-09-25
AU6856190A (en) 1991-07-04
NO173733B (no) 1993-10-18
JPH0714913B2 (ja) 1995-02-22
ATE133941T1 (de) 1996-02-15
CN1053059A (zh) 1991-07-17
EP0436332B1 (fr) 1996-02-07

Similar Documents

Publication Publication Date Title
GR3019487T3 (en) Polyamines useful as antagonists of excitatory amino acid neurotransmitters
CA2015505A1 (fr) Polyamines et polypeptides utiles comme antagonistes des acides amines excitants des neurotransmetteurs et/ou comme bloqueurs des canaux calciques
FI112471B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten hydroksietyyliaminosulfoniamidien valmistamiseksi
HUT46708A (en) Process for producing heterocyclic ketones and pharmaceutical compositions containing them as active components
OA09982A (fr) Derives heterocycliques leur procede de production et composition pharmaceutique les contenant
AU621483B2 (en) Azaindenes
AU6320394A (en) Aryl substituted heterocycles
NO20001764L (no) FremgangsmÕte for fremstilling av melkesyre, og syretolerant homolaktisk bakterie
DE3875792D1 (de) Neues herbizid, seine herstellung und seine verwendung.
FI895185A0 (fi) Mevalonolaktoner av tienopyridintyp.
HUT55036A (en) Process for producing polypeptides blocking the calcium duct
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
FI893682A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
DE69503093D1 (de) Verfahren zur Herstellung von Guaniden
HU9303505D0 (en) Process for producing organic compound
ATE110730T1 (de) Verfahren zur herstellung von cephalosporinen.